Maintenance after GLP-1

Composition-First Maintenance After GLP-1 Weight Loss

After weight loss with medicines such as semaglutide or tirzepatide, the best target is rarely just the lowest number on the scale. The stronger target is a body that can function, eat, train and maintain.

Élan Clinic · Educational resource · Published June 17, 2026

8 min readBody compositionWeight maintenance

Many patients feel disappointed when their weight rises after a GLP-1 medicine is reduced, paused or stopped. The natural reaction is to chase the lowest number again.

That reaction is understandable. It is also too narrow.

The scale measures total weight. It does not show how much is fat mass, lean tissue, water, glycogen or digestive contents. It also does not measure strength, fitness, protein intake, sleep, appetite control or whether the plan can survive normal life.

Élan's view: maintenance after GLP-1 treatment should be composition-first. The goal is not only to weigh less. The goal is to preserve function, strength and metabolic health while building a realistic plan for the months after major weight loss.

Why the lowest number can be the wrong target

Two people can weigh the same and have very different health positions. One may have more lean tissue, better strength and a stable food structure. The other may have lost more lean tissue, be under-eating protein and rely on appetite suppression alone.

During treatment with GLP-1 or GIP/GLP-1 medicines, large weight loss can include both fat mass and lean mass. Lean mass is not the same as skeletal muscle. It includes muscle, water, glycogen, bone, organs and other non-fat tissue. This distinction matters because the goal is not to create fear about muscle loss. The goal is to avoid ignoring body composition completely.

In the SURMOUNT-1 tirzepatide body-composition substudy, most weight lost was fat mass, but a smaller proportion was lean mass measured by DXA. That is broadly reassuring, but it does not remove the need for protein, resistance training and monitoring in individual patients.

Practical example, not a target:

A patient at 78 kg with better strength, improved waist measurement and a sustainable eating routine may be in a stronger maintenance position than the same patient at 72 kg after aggressive restriction, low protein and reduced training capacity.

What composition-first maintenance means

Composition-first maintenance changes the question.

Instead of asking only, "How much weight did I lose?" ask:

This does not make the scale useless. It makes the scale one signal among several.

StrengthTrack function, not only weight.
ProteinPlan intake around appetite and medical context.
TrainingUse progressive resistance work where appropriate.

The medication context

Different brands and medicines have different approved uses. In the EU, Ozempic is indicated for adults with insufficiently controlled type 2 diabetes. Wegovy is indicated for weight management in eligible adults and adolescents. Mounjaro is indicated for adults with type 2 diabetes and for weight management in eligible adults. This article does not claim that every named medicine has the same indication or that any specific medicine is suitable for you.

Weight regain after stopping obesity pharmacotherapy is common in trials. That does not mean stopping is always wrong, or that everyone must stay on medication indefinitely. It means the transition should be planned, monitored and individualised.

A safer composition-first plan

1. Set more than one metric

If body-composition testing is available, use it as one tool, not as a perfect truth. If it is not available, use practical proxies: waist measurement, strength in key exercises, walking capacity, energy, clothing fit and whether function is improving or declining.

2. Make protein practical

Many adults trying to preserve or build muscle during weight loss need deliberate protein planning, especially when appetite is low. A common planning anchor in weight-loss and resistance-training settings is around 1.6 g per kg of target or ideal body weight per day, adjusted for age, kidney function, digestive symptoms, medication side effects and overall medical context.

This number is not a prescription for everyone. Kidney disease, frailty, eating-disorder risk, nausea, vomiting or other medical issues change the plan. The point is to stop leaving protein to chance.

3. Prioritise resistance training

Cardio is useful for cardiovascular health. It is not the same as a muscle-preservation plan.

For many patients, progressive resistance training is the missing piece: weights, machines, bodyweight work or bands, adapted to current ability and injury risk. The exact programme should be realistic enough to repeat, not impressive for one week.

4. Do not panic over every kilogram

Some short-term weight movement can reflect water, glycogen, digestive contents, menstrual cycle changes, sodium intake, constipation and normal appetite variation. Panic restriction can worsen the situation if it reduces protein intake, training capacity or mood.

The better response is structured: review food rhythm, protein, resistance training, sleep, alcohol, constipation, medication plan and follow-up timing.

5. Plan the transition early

The vulnerable period is often when medication is reduced, interrupted or stopped and the patient expects the result to hold without a new structure. This is when appetite, habits, social eating and old weight-regain patterns can reappear.

If you are considering starting, stopping, pausing or changing a medicine, discuss it with your prescribing clinician. This article is education, not a personal treatment instruction.

When to seek medical help

Contact a clinician urgently if you have severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down, signs of dehydration, fainting, severe weakness, chest symptoms, symptoms of low blood sugar if you use insulin or a sulfonylurea, or thoughts of self-harm.

If you are pregnant, trying to conceive, breastfeeding, have kidney disease, a history of pancreatitis, gallbladder disease, eating-disorder history or complex medication use, do not make medication or diet changes without medical advice.

The takeaway

The number on the scale is a measurement. It is not the whole goal.

After GLP-1 weight loss, a stronger maintenance plan asks what kind of body is being maintained: stronger or weaker, nourished or under-fuelled, monitored or guessed, realistic or dependent on perfect appetite suppression.

The better question is not only, "Can I get back to my lowest weight?" It is, "Can I build a body and routine that can hold the result safely?"

Build the maintenance plan before regain starts.

Élan Clinic focuses on weight maintenance, body composition and regain planning after GLP-1 treatment. A consultation can help you review protein, training, monitoring and medication-transition questions around your situation.

Book a consultation

Sources

  1. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384:989-1002. Randomized trial, n=1961. PMID: 33567185. DOI: 10.1056/NEJMoa2032183. Funded by Novo Nordisk.
  2. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA. 2021;325(14):1414-1425. STEP 4 randomized withdrawal trial. PMID: 33755728. DOI: 10.1001/jama.2021.3224. Funded by Novo Nordisk.
  3. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564. PMID: 35441470. DOI: 10.1111/dom.14725. Funded by Novo Nordisk.
  4. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216. Randomized trial, n=2539. PMID: 35658024. DOI: 10.1056/NEJMoa2206038. Supported by Eli Lilly.
  5. Look M et al. Body composition changes during weight reduction with tirzepatide in SURMOUNT-1. Diabetes, Obesity and Metabolism. 2025;27(5):2720-2729. DXA substudy, n=160. PMID: 39996356. DOI: 10.1111/dom.16275. Supported by Eli Lilly.
  6. Morton RW et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength. British Journal of Sports Medicine. 2018;52(6):376-384. PMID: 28698222. DOI: 10.1136/bjsports-2017-097608.
  7. Verreijen AM et al. A high whey protein-, leucine-, and vitamin D-enriched supplement preserves muscle mass during intentional weight loss in obese older adults. American Journal of Clinical Nutrition. 2015;101(2):279-286. PMID: 25646324. DOI: 10.3945/ajcn.114.090290.
  8. European Medicines Agency. Ozempic, Wegovy and Mounjaro EPAR product information. Current EU product information should be checked before applying indication, pregnancy or safety wording to an individual patient.